Similarly, the simultaneous combination of irinotecan and sunitinib (a multi-targeted receptor tyrosine kinase inhibitor) induced apoptosis in the ATC cells 8305C and FB3 cells, and decreased tumor growth in ATC xenografts [44]. This evidence concerns the gene NTRK1 and neoplasm.